Spironolactone Is Secure and Reduces Left Ventricular Hypertrophy in Hemodialysis Patients
Therapeutic Advances in Cardiovascular Disease - United Kingdom
doi 10.1177/1753944715591448
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2015
Authors
Publisher
SAGE Publications